Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli

BACKGROUND/AIMS: The number of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is increasing. In an outpatient setting, there are limited therapeutic options to treat ESBL-producing pathogens. We evaluated the outcomes of amikacin outpatie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sung-Yeon, Choi, Su-Mi, Park, Sun Hee, Lee, Dong-Gun, Choi, Jung-Hyun, Yoo, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712420/
https://www.ncbi.nlm.nih.gov/pubmed/26767869
http://dx.doi.org/10.3904/kjim.2016.31.1.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712420/
https://www.ncbi.nlm.nih.gov/pubmed/26767869
http://dx.doi.org/10.3904/kjim.2016.31.1.156

Ejemplares similares